Qiagen NV (QGEN) is a Healthcare · Diagnostics & Research company listed on NYSE. Price $43.68 (-1.58%), Market cap $6.80B, P/E ratio 16.83, 52-week low–high $32.63 ~ $55.66.
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and as
Financial statements, price targets, institutional (13F) holdings and related news for Qiagen NV are updated in real time on BlackAll Trade.
Qiagen NV trades at $43.68 (-1.58%). Real-time quotes and charts are available on BlackAll Trade.
Qiagen NV has a market cap of about $6.80B. Its P/E ratio is 16.83.
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilizati